Prophylactic antibiotics to prevent cellulitis of the leg: Economic analysis of the patch I & II trials

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Mason, James M ^a   Thomas, Kim S ^b   Crook, Angela M ^c   Foster, Katharine A ^b   Chalmers, Joanne R ^b   Nunn, Andrew J ^c   Williams, Hywel C ^b  

^a DURHAM UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN V;

ADULT; AGED; ARTICLE; CELLULITIS; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DERMATOLOGY LIFE QUALITY INDEX; DRUG COST; FEMALE; FOLLOW UP; HUMAN; INFECTION PREVENTION; IRELAND; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; OUTCOME ASSESSMENT; PROBABILITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; UNITED KINGDOM;

AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CELLULITIS; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; FEMALE; HUMANS; LEG; MALE; MIDDLE AGED; QUALITY OF LIFE; RECURRENCE; TREATMENT OUTCOME;

EID: 84895886409     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082694     Document Type: Article

References (25)

1. Cox NH. (2006) Oedema as a risk factor for multiple episodes of cellulitis/erysipelas of the lower leg: a series with community follow-up. British Journal of Dermatology 155: 947-50.
2. Jeng A, Beheshti M, Li J, Nathan R. (2010) The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation. Medicine 89: 217-26.
3. Bernard P, Bedane C, Mounier M, Denis F, Catanzano G, Bonnetblanc JM. (1989) Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique. Arch Dermatol. 125: 779-82. (Pubitemid 19161120)
4. Levell N, Wingfield C, Garioch J. (2011) Severe lower limb cellulitis is best diagnosed by dermatologists and managed with shared care between primary and secondary care. British Journal of Dermatology 164: 1326-8.
5. Soo JK, Bicanic TA, Heenan S, Mortimer PS. (2008) Lymphatic abnormalities demonstrated by lymphoscintigraphy after lower limb cellulitis. British Journal of Dermatology 158: 1350-53. (Pubitemid 351692850)
6. British Medical Association, Royal Pharmaceutical Society of Great Britain. (2010) British National Formulary. Pharmaceutical Press; 59th Revised edition. ISBN-13: 978-0853699293.
7. Thomas KS, Crook AM, Nunn AJ, Foster KA, Mason JM, Chalmers JR, Nasr IS, Brindle RJ, English BS, Meredith SK, Reynolds NJ, de Berker D, Mortimer PS, Williams HC on behalf of the UK Dermatology Clinical Trials Network's PATCH I Trial Team. (2013) Penicillin to Prevent Leg Cellulitis Recurrence: randomized controlled trial. New England Journal of Medicine 368; 1695-1703.
8. UK Dermatology Clinical Trials Network's PATCH Trial Team, Thomas K, Crook A, Foster K, Mason J, Chalmers J, Bourke J, Ferguson A, Level N, Nunn A, Williams H. (2012) Prophylactic antibiotics for the prevention of cellulitis (erysipelas) of the leg: results of the UK Dermatology Clinical Trials Network's PATCH II trial. Br J Dermatol. 166: 169-78.
9. Kremer M, Zuckerman R, Avraham Z, Raz R. (1991) Long-term antimicrobial therapy in the prevention of recurrent sort-tissue infections. Journal of Infection 122: 37-40.
10. Sjoblom AC, Eriksson B, Jorup-Ronstrom C, Karkkonen K, Lindqvist M. (1993) Antibiotic prophylaxis in recurrent erysipelas. Infection 21: 390-3.
11. Chakroun M, Ben-Romdhane F, Battikh R, Souki A, Bouzouaia N. (1994) Benzathine penicillin prophylaxis in recurrent erysipelas. Mal Med Infect 24: 894-7. (Pubitemid 24344274)
12. Cox NH, Colver GB, Paterson WD. (1998) Management and morbidity of cellulitis of the leg. Journal of the Royal Society of Medicine 91: 634-7. (Pubitemid 29017595)
13. Jorup-Ronstrom C, Britton S. (1987) Recurrent erysipelas: predisposing factors and costs of prophylaxis. Infection 15: 105-6. (Pubitemid 17051548)
14. Hospital Episode Statistics. (2011) HESOnline: Inpatient data, primary diagnosis (4 character). http://www.hesonline.nhs.uk/(last accessed 28-3-2013).
15. Curtis L. (2012) Unit Costs of Health and Social Care 2011, University of Kent http://www.pssru.ac.uk/project-pages/unit-costs/2011/index.php; last accessed 28-3-2013.
16. Goettsch WG, Bouwes Bavinck JN, Herings RM. (2006) Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands. J Eur Acad Dermatol Venereol. 20: 834-9. (Pubitemid 44102917)
17. Kind P, Dolan P, Gudex C, Williams A. (1998) Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 316: 736-41. (Pubitemid 28121072)
18. Finlay AY, Khan GK. (1994) Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 19: 210-6. (Pubitemid 24194579)
19. Department of Health. (2012) NHS Hospital Trust Reference Costs 2010-11 http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH-131140 (last accessed 13/9/2012).
20. NHS Information Centre. (2012) HRG4 2010/11 Reference Costs Grouper Documentation http://www.ic.nhs.uk/services/the-casemix-service/using-this- service/reference/archived-past-groupers-and-documentation/costing/ hrg4-2010-11-reference-costs-grouper-documentation (last accessed 13/9/2012).
21. Office for National Statistics. (2011) Annual Survey of Hours and Earnings, 2010 Revised Results http://www.ons.gov.uk/ons/rel/ashe/annual-survey- of-hours-and-earnings/2010-revised-results/index.html (last accessed 13/9/2012).
22. Barber JA, Thompson SG. (2000) Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med 19: 3219-36.
23. Fenwick E, O'Brien BJ Briggs A. (2004) Cost-effectiveness acceptability curves - facts, fallacies and frequently asked questions. Health Economics 13: 405-415. (Pubitemid 38660390)
24. National Institute for Health and Clinical Excellence. (2008) Updated guide to the methods of technology appraisal. http://www.nice.org.uk/aboutnice/ howwework/devnicetech/guidetothemethodsoftechnologyappraisal.jsp (last accessed 13/9/2012).
25. CREST. (2005) Guidelines on the management of cellulitis in adults. http://www.gain-ni.org/Publications/Guidelines/Management-Cellulitis-Adults.asp (last accessed 13/9/2012).